R&D Views & Analysis | pharmaphorum

Views & Analysis

R&D

The continued search for a cure to HIV

Not very long ago, contracting HIV was an effective death sentence; today, there are treatments that allow the condition to be managed but not eradicated.

Market Access

Philips on designing innovation and cultivating partnerships...

Sachin Grover, lead of solutions vertical at Philips India, tells me about the company's innovations during India's COVID outbreak and how they've led to increased healthcare access in the

R&D

CanSinoBIO developed a highly effective COVID vaccine with a...

Pierre A.

R&D

Preventing the next pandemic: Infrastructure and global equi...

In the final piece of a three-part series, Ben Hargreaves explores how manufacturing infrastructure was rapidly built up to the required capacity to ensure sufficient supply of COVID-19 vac

R&D

For neurological disease, solving measurement is the first a...

Neurodegenerative diseases like Parkinson’s and Alzheimer’s affect millions of people worldwide, and their prevalence is only increasing, according to the World Health Organization.

R&D

Study highlights the multibillion dollar burden of rare dise...

Annie Kennedy, chief of policy, advocacy, and patient engagement at the EveryLife Foundation for Rare Diseases, tells us why the Foundation sponsored The National Economic Burden of Rare Di